Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and Revision: v3.4.1 removed; the government funding/operating status notice was deleted.
    Difference
    0.4%
    Check dated 2026-02-11T11:38:28.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations is now displayed, and the page shows a new revision tag (v3.4.1) replacing the previous v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:20:52.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The updates are minor UI and text changes: a glossary display was added, capitalization adjustments to QC-related labels, and the revision note updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:20:57.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing v3.3.3. This is a minor site version update and does not alter study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:14:55.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section appears with California listed as a site. The footer revision note updates to Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:29:39.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.